Sam Eletr Trust

The Sam Eletr Trust is a private investment vehicle and family office associated with the estate of Sami Eletr, a pioneering entrepreneur and co-founder of Applied Biosystems. The trust focuses its activities on the life sciences sector, particularly within genomics, molecular diagnostics, and laboratory instrumentation. It has historically maintained significant equity positions in prominent biotechnology firms such as Cepheid and Fluidigm (now Standard BioTools). Rather than operating as a research-based biotechnology company with a proprietary drug pipeline, the trust serves as a strategic holding entity for venture and equity investments. Its legacy is deeply linked to the commercialization of automated DNA sequencing and PCR technologies that defined the modern genomic era. The entity is frequently identified in regulatory filings as a major stakeholder in companies developing advanced life science tools.